{"resourceType":"Observation","id":"82b6e522-c67e-5319-a112-fe33249e1af3","meta":{"versionId":"1","lastUpdated":"2022-05-24T16:39:30.861-04:00","source":"#vygfSfBMYC50a1gC","profile":["http://fhir.mimic.mit.edu/StructureDefinition/mimic-observation-micro-test"]},"identifier":[{"system":"http://fhir.mimic.mit.edu/identifier/observation-micro-test","value":"6369611-90134"}],"status":"final","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/observation-category","code":"laboratory"}]}],"code":{"coding":[{"system":"http://fhir.mimic.mit.edu/CodeSystem/microbiology-test","code":"90134","display":"EPSTEIN-BARR VIRUS VCA-IgM AB"}]},"subject":{"reference":"Patient/1cf9e585-806c-513b-80af-4ca565a28231"},"effectiveDateTime":"2191-09-18T16:20:00-04:00","valueString":"NEGATIVE <1:10 BY IFA.  INTERPRETATION: RESULTS INDICATIVE OF PAST EBV INFECTION.  In most populations, 90% of adults have been infected at sometime with EBV and will have measurable VCA IgG and EBNA antibodies. Antibodies to EBNA develop 6-8 weeks after primary infection and remain present for life. Presence of VCA IgM antibodies indicates recent primary infection.  ","specimen":{"reference":"Specimen/b39b0d38-cd99-55d6-ae8e-f17afd8cdd33"}}